Searched for
KRISHNA M ELLA
Microsoft's Nadella and Google's Pichai among Padma awardees, Sonu Nigam receives the Padma ShriOlympic gold medallist Neeraj Chopra was also conferred the Padma Shri.
Suresh Jadhav, key executive of SII & doyen of vaccine industry, passed awayJadhav has been with SII for over four decades, playing a crucial role in building SII as the world's largest vaccine producer. As part of ...
Bharat Biotech's Covaxin gets WHO okay for emergency useHyderabad-based Bharat Biotech, which has developed Covaxin, submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine'...
Biological E plans to break into the big league by manufacturing three Covid-19 vaccinesOf these, the phase-three trials of Corbevax — jointly manufactured by BE, Baylor College of Medicine in Houston and Dynavax in California ...
Covaxin priced at ₹600 and ₹1200 for state and private hospitals respectively
Controversy swirls around India’s homegrown Covid-19 vaccineFrom the U.S. to the Norway, vociferous debates over the efficacy and safety of Covid-19 vaccines have beset pharmaceutical giants like Pfi...
How Krishna Ella built Bharat Biotech and why the company is at a tipping pointBharat Biotech’s Covaxin is India’s first indigenous coronavirus vaccine. The DCGI’s approval of Covaxin, despite it not having phase-3 cli...
SGX Nifty down 100 points; here's what changed for market while you were sleepingAsian shares edged lower on Tuesday amid uncertainty about Senate runoffs in Georgia, which could have a big impact on incoming US Presiden...
COVID-19 vaccine approval: All risks paid off, proud moment for India, say SII, Bharat BiotechPune-based vaccine major Serum Institute of India (SII) had entered into a collaboration with the University of Oxford and AstraZeneca to m...
Bennett University to organise global online conference on combating coronavirus through biotechThis will be the second online conference that Bennett University will be organising in less than a week. At a time when leading research l...
Hope to get nasal vaccine against Covid-19 into market in 12-18 months: Hyderabad-based Bharat BiotechKrishna M Ella, a molecular biologist and chairman and managing director of the Bharat Biotech, spoke to TOI's Surendra Singh in an exclusi...
Hyderabad pharma company Bharat Biotech unveils new typhoid vaccineBharat Biotech launched what it claimed was the world's first clinically proven typhoid conjugate vaccine, Typbar - TCV.
- Scientists unveils first Made in India rotavirus vaccine
Scientists today unveiled the first completely indigenous and affordable vaccine to prevent severe rotavirus diarrhoea, which kills more th...
- Bharat Biotech launches COMVAC5 vaccines
Bharat Biotech has launched COMVAC5, a single shot pentavalent combination vaccine used for treating diseases such as Diptheria, Pertussis,...
- Genetically modified crops are order of the day: Govt
The government feels India should accept that genetically modified seeds is the solution to feed the growing population.